Herbs and alternative therapies: Relevance to hypertension and cardiovascular diseases

Current Hypertension Reports

Volumn 7, Issue 4, 2005, Pages 275-280

  Vora, Chaula K ^a   Mansoor, George A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CYCLOSPORIN; DIGOXIN; FELODIPINE; GARLIC EXTRACT; GINSENG EXTRACT; GINSENOSIDE; GLYCOSIDE; GLYCYRRHETINIC ACID; GLYCYRRHIZA GLABRA EXTRACT; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; MEVINOLIN; NICARDIPINE; NIFEDIPINE; NISOLDIPINE; NITRENDIPINE; ORAL CONTRACEPTIVE AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; SEROTONIN UPTAKE INHIBITOR; SIMVASTATIN; TACROLIMUS; UNINDEXED DRUG; WARFARIN; YOHIMBINE;

AGRANULOCYTOSIS; ALTERNATIVE MEDICINE; ANAMNESIS; AWARENESS; BODY WEIGHT DISORDER; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPETENCE; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; ENERGY; EVIDENCE BASED MEDICINE; GRAPEFRUIT JUICE; HEALTH PRACTITIONER; HERBAL MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; MANIA; MANIPULATIVE MEDICINE; MEDICAL CARE; METABOLIC ACIDOSIS; PHYSICIAN; RAYNAUD PHENOMENON; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA; THROMBOEMBOLISM; WEIGHT GAIN;

EID: 24944503656     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-005-0025-0     Document Type: Review

References (59)

1. Winslow LC, Kroll DJ: Herbs as medicines. Arch Intern Med 1998, 158:2192-2199.
2. Miller KL, Liebowitz RS, Newby LK: Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J 2004, 147:401-411.
3. Rafferty AP, McGee HB, Miller CE, et al.: Prevalence of complementary and alternative medicine use: state-specific estimates from the 2001 Behavioral Risk Factor Surveillance System. Am J Public Health 2002, 92:1598-1600.
4. CDC: Self-treatment with herbal and other plant-derived remedies - rural Mississippi, 1993. MMWR Morb Mortal Wkly Rep 1995, 44:204-207.
5. Harnack LJ, Rydell SA, Stang J: Prevalence of use of herbal products by adults in the Minneapolis/St. Paul, Minn, metropolitan area. Mayo Clin Proc 2001, 76:688-694.
6. Final report of the White House Commission on Complementary and Alternative Medicine Policy. Available online at http://www.whccamp.hhs.gov/fr7.html
7. Eisenberg DM, Davis RB, Ettner SL, et al.: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998, 280:1569-1575.
8. Cappuccio FP, Duneclift SM, Atkinson RW, et al.: Use of alternative medicines in a multi-ethnic population. Ethn Dis 2000, 11:11-18.
9. Mikhail N, Wali S, Ziment I: Use of alternative medicine among Hispanics. J Altern Complement Med 2004, 10:851-859.
10. Eisenberg DM, Kessler RC, Van Rompay MI, et al.: Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001, 135:344-351.
11. Palinkas LA, Kabongo ML: San Diego Unified Practice Research in Family Medicine Network. The use of complementary and alternative medicine by primary care patients. A SURF*NET study. J Fam Pract 2000, 49:1121-1130.
12. Fields LE, Burt VL, Cutler JA, et al.: The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004, 44:398-404.
13. Cohen MH: Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation. Dermatol Ther 2003, 16:777-784.
14. US Food and Drug Administration: Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Docket number: 1995N-0304. http://www.fda.gov/OHRMS/DOCKETS/98fr/1995n-0304-nfr0001.pdf. 2004.
15. Banerjee SK, Maulik SK: Effect of garlic on cardiovascular disorders: a review. Nutr J 2002, 1:4.
16. Das I, Khan NS, Sooranna SR: Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin 1995, 13:257-263.
17. Sharifi AM, Darabi R, Akbarloo N: Investigation of antihypertensive mechanism of garlic in 2K1C hypertensive rat. J Ethnopharmacol 2003, 86:219-224.
18. Ackermann RT, Mulrow CD, Ramirez G, et al.: Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001, 161:813-824.
19. Silagy CA, Neil HA: A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994, 12:463-468.
20. Turner B, Molgaard C, Marckmann P: Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2004, 92:701-706.
21. Piscitelli SC, Burstein AH, Welden N, et al.: The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002, 35:234-238.
22. Knuppel L, Linde K: Adverse effects of St. John's Wort: a systematic review. J Clin Psychiatry 2004, 65:1470-1479.
23. Bilia AR, Gallori S, Vincieri FF: St. John's Wort and depression: efficacy, safety and tolerability: an update. Life Sci 2002, 70:3077-3096.
24. Hypericum Depression Trial Study Group: Effect of Hypericum perforatum (St. John's Wort) in major depressive disorder: a randomized controlled trial. JAMA 2002, 287:1807-1814.
25. Zullino D, Borgeat F: Hypertension induced by St. John's Wort: a case report. Pharmacopsychiatry 2003, 36:32.
26. Patel S, Robinson R, Burk M: Hypertensive crisis associated with St. John's Wort. Am J Med 2002, 112:507-508.
27. Markowitz JS, Donovan JL, DeVane CL, et al.: Effect of St John's Wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003, 290:1500-1504.
28. Mueller SC, Uehleke B, Woehling H, et al.: Effect of St John's Wort dose and preparations on the pharmacokinetics of digoxin. Clin Pharmacol Ther 2004, 75:546-557.
29. Sugimoto K, Ohmori M, Tsuruoka S, et al.: Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001, 70:518-524.
30. Jiang X, Williams KM, Liauw WS, et al.: Effect of St John's Wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.Br J Clin Pharmacol 2004, 57:592-599.
31. Tannergren C, Engman H, Knutson L, et al.: St John's Wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Clin Pharmacol Ther 2004, 75:298-309.
32. Mai I, Bauer S, Perloff ES, et al.: Hyperforin content determines the magnitude of the St John's Wort-cyclosporine drug interaction. Clin Pharmacol Ther 2004, 76:330-340.
33. Hebert MF, Park JM, Chen YL, et al.: Effects of St. John's Wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 2004, 44:89-94.
34. Ruschitzka F, Meier PJ, Turina M, et al.: Acute heart transplant rejection due to St. John's Wort. Lancet 2000, 355:548-549.
35. Ernst E: St John's Wort supplements endanger the success of organ transplantation. Arch Surg 2002, 137:316-319.
36. Piscitelli SC, Burstein AH, Chaitt D, et al.: Indinavir concentrations and St. John's Wort. Lancet 2000, 355:547-548.
37. de Maat MM, Hoetelmans RM, Math t RA, et al.: Drug interaction between St John's Wort and nevirapine. AIDS 2001, 15:420-421.
38. Hall SD, Wang Z, Huang SM, et al.: The interaction between St John's Wort and an oral contraceptive. Clin Pharmacol Ther 2003, 74:525-535.
39. Han KH, Choe SC, Kim HS, et al.: Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. Am J Chin Med 1998, 26:199-209.
40. Caron MF, Hotsko AL, Robertson S, et al.: Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother 2002, 36:758-763.
41. Cicero AF, Derosa G, Brillante R, et al.: Effects of Siberian ginseng on elderly quality of life: a randomized clinical trial. Arch Gerontol Geriatr Suppl 2004, 15:69-73.
42. Achike FI, Kwan CY: Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway. Clin Exp Pharmacol Physiol 2003, 30:605-615.
43. Siegel RK: Ginseng abuse syndrome. Problems with the panacea. JAMA 1979, 241:1614-1615.
44. Yuan CS, Wei G, Dey L, et al.: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann Intern Med 2004, 141:23-27.
45. Walker BR, Edwards CR: Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. Endocrinol Metab Clin North Am 1994, 23:359-377.
46. Quinkler M, Stewart PM: Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab 2003, 88:2384-2392.
47. Russo S, Mastropasqua M, Mosetti MA, et al.: Low doses of liquorice can induce hypertension encephalopathy. Am J Nephrol 2000, 20:145-148.
48. Hasegawa J, Suyama Y, Kinugawa T, et al.: Echocardiographic findings of the heart resembling dilated cardiomyopathy during hypokalemic myopathy due to licorice-induced pseudoaldosteronism. Cardiovasc Drugs Ther 1998, 12:599-600.
49. Lin SH, Yang SS, Chau T, et al.: An unusual cause of hypokalemic paralysis: chronic licorice ingestion. Am J Med Sci 2003, 325:153-156.
50. Dellow EL, Unwin RJ, Honour JW: Pontefract cakes can be bad for you: Refractory hypertension and liquorice excess. Nephrol Dial Transplant 1999, 14:218-220.
51. Sigurjonsdottir HA, Manhem K, Axelson M, et al.: Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. J Hum Hypertens 2003, 17:125-131.
52. Grossman E, Rosenthal T, Peleg E, et al.: Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol 1993, 22:22-26.
53. Goldberg MR, Hollister AS, Robertson D: Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans. Hypertension 1983, 5:772-778.
54. Musso NR, Vergassola C, Pende A, et al.: Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. Am J Hypertens 1995, 8:557-565.
55. Ruck B, Shih RD, Marcus SM: Hypertensive crisis from herbal treatment of impotence. Am J Emerg Med 1999, 17:317-318.
56. Onrot J, Goldberg MR, Biaggioni I, et al.: Oral yohimbine in human autonomic failure. Neurology 1987, 37:215-220.
57. Ernst E, Pittler MH: Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998, 159:433-436.
58. Kane GC, Lipsky JJ: Drug-grapefruit interactions. Mayo Clin Proceed 2000, 75:933-942.
59. Huang SM, Hall SD, Watkins P, et al.: Center for Drug Evaluation and Research and Office of Regulatory Affairs, Food and Drug Administration, Rockville, MD, USA. Drug interactions with herbal products and grapefruit juice: a conference report. Clin Pharmacol Ther 2004, 75:1-12.